Drug recall D-0551-2025
Product
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Reason for recall
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
Lots and codes
Lot # K24118, exp. date 10/31/2026
Recall details
- Recalling firm
- Hikma Pharmaceuticals USA Inc., Cherry Hill, NJ
- Quantity
- 382,775 1mL vials
- Distribution
- Distributed Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 22, 2025
Related products
- Lorazepam – drug information
- NDC 0641-6045 Lorazepam · Lorazepam 4 mg/mL · Hikma Pharmaceuticals USA Inc.
- NDC 0641-6047 Lorazepam · Lorazepam 4 mg/mL · Hikma Pharmaceuticals USA Inc.
- NDC 0641-6044 Lorazepam · Lorazepam 2 mg/mL · Hikma Pharmaceuticals USA Inc.
- NDC 0641-6046 Lorazepam · Lorazepam 2 mg/mL · Hikma Pharmaceuticals USA Inc.